TelyRx Holdings has partnered with SISTERLY, an Irish women's health brand, to offer nutritional supplements alongside prescription menopause treatments. This collaboration introduces The Elevator, a daily multivitamin designed to support women's health during perimenopause and menopause, to TelyRx's U.S. pharmacy platform. The partnership aims to provide women with more personalized options for managing menopause symptoms, enhancing TelyRx's existing digital healthcare services. The launch coincides with World Menopause Month, highlighting TelyRx's commitment to broadening women's health offerings.
TelyRx's new menopause supplement launch provides context for the health sector's recent market activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 07, 2026 18:11 WIB: of 100 priced Health-sector US stocks, 52 rose and 38 fell. Notable movers include HRTX at USD 0.34 with a 1-day change of +2.50% and Pluang order activity of 54% Sell / 46% Buy, TXG at USD 78.70 down -2.43% with 46% Sell / 54% Buy, and MESO at USD 13.93 up +2.35%. Typical hold times on Pluang range from 14 to 92 days among these stocks.
Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...
Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...
Barclays has lowered its price target for Netflix shares from $80 to $70 due to concerns over slower revenue growth and rising content costs, especially for live programming. Despite Netflix's large subscriber base of 325 million, the company faces p...
Barclays has increased its price target for MetLife stock to $111 from $97, indicating potential upside as shares currently trade near $97.16. MetLife also declared a fourth-quarter 2026 dividend of $0.59 per common share, payable on December 8, 2026...
Nasdaq is enhancing its Calypso platform with agentic AI to improve trading and risk management, addressing manual post-trade tasks in financial services. Its Financial Technology unit saw 16% revenue growth and added numerous new clients, driven by ...
